Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|July 28, 2022
Role of Diet in Stem and Cancer Stem CellsFrancesca Puca, Monica Fedele, Debora Rasio, et al.
Frontiers in Medicine|April 11, 2015
High mobility group a proteins as tumor markersPierlorenzo Pallante, Romina Sepe, Francesca Puca, et al.
Biology Direct|April 3, 2026
Plasma metabolomic profiling identifies a metabolic signature for non-muscle-invasive bladder cancer independent of hematuriaRoberto Speziale, Valerio Iacovelli, Guido Leoni, et al.
Nature|January 11, 2018
Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescenceGabriele Sulli, Amy Rommel, Xiaojie Wang, et al.
Oncotarget|May 17, 2014
HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levelsFrancesca Puca, Marianna Colamaio, Antonella Federico, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2014
miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1Marianna Colamaio, Francesca Puca, Elvira Ragozzino, et al.
Cell Cycle (Georgetown, Tex.)|May 23, 2019
HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cellsFrancesca Puca, Nadia Tosti, Antonella Federico, et al.
Expert Opinion on Therapeutic Targets|August 4, 2016
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cellsMarianna Colamaio, Nadia Tosti, Francesca Puca, et al.
Cancer Discovery|May 27, 2021
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in GlioblastomaFrancesca Puca, Fei Yu, Caterina Bartolacci, et al.
Cancer Cell|February 13, 2019
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid TumorsAlessandro Carugo, Rosalba Minelli, Luigi Sapio, et al.
Pageof 1